Approval for the use of t-cell xtend reagent in extending whole blood storage from 0-32 hours prior to assaying with the t-spot. Tb test.
Device | T-SPOT .TB TEST |
Generic Name | Mycobacterium Tuberculosis, Cell Mediated Immune Response, Enzyme-linked Immunospot Test |
Applicant | OXFORD IMMUNOTEC,LTD. |
Date Received | 2011-07-12 |
Decision Date | 2012-01-04 |
PMA | P070006 |
Supplement | S006 |
Product Code | OJN |
Advisory Committee | Microbiology |
Supplement Type | Normal 180 Day Track |
Supplement Reason | Labeling Change - Indications/instructions/shelf Life/tradename |
Expedited Review | No |
Combination Product | No |
Applicant Address | OXFORD IMMUNOTEC,LTD. 94c Innovation Drive milton Park, Abingdon Oxfordshire OX14 |
Supplemental Filings
Supplement Number | Date | Supplement Type |
P070006 | | Original Filing |
S017 |
2021-05-03 |
Normal 180 Day Track No User Fee |
S016 |
2021-03-09 |
30-day Notice |
S015 | | |
S014 |
2020-03-30 |
Normal 180 Day Track |
S013 |
2020-03-10 |
30-day Notice |
S012 |
2019-12-05 |
Real-time Process |
S011 |
2013-02-19 |
135 Review Track For 30-day Notice |
S010 | | |
S009 |
2012-09-04 |
135 Review Track For 30-day Notice |
S008 |
2012-08-27 |
Real-time Process |
S007 |
2011-11-17 |
Real-time Process |
S006 |
2011-07-12 |
Normal 180 Day Track |
S005 |
2011-04-06 |
30-day Notice |
S004 |
2010-02-18 |
30-day Notice |
S003 |
2009-10-01 |
Real-time Process |
S002 |
2009-09-30 |
30-day Notice |
S001 |
2009-02-27 |
Normal 180 Day Track |
NIH GUDID Devices